VIGNAROLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 1.225
EU - Europa 769
AS - Asia 155
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
AF - Africa 1
Totale 2.155
Nazione #
US - Stati Uniti d'America 1.221
GB - Regno Unito 260
IE - Irlanda 158
CN - Cina 123
SE - Svezia 89
UA - Ucraina 79
IT - Italia 70
DE - Germania 34
FR - Francia 33
FI - Finlandia 22
TR - Turchia 9
RU - Federazione Russa 8
IR - Iran 7
CZ - Repubblica Ceca 6
SG - Singapore 6
BE - Belgio 4
CA - Canada 4
ES - Italia 3
EU - Europa 3
IN - India 3
JO - Giordania 2
JP - Giappone 2
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
NO - Norvegia 1
PH - Filippine 1
TH - Thailandia 1
Totale 2.155
Città #
Southend 227
Dublin 156
Menlo Park 152
Fairfield 145
Chandler 117
Woodbridge 101
Ashburn 85
Seattle 78
Wilmington 75
Jacksonville 68
Houston 63
Ann Arbor 59
Cambridge 56
Beijing 47
Siena 41
New York 31
Princeton 28
Nanjing 20
San Diego 13
Boardman 12
Shanghai 12
Lancaster 11
Dearborn 9
Fremont 7
Helsinki 7
Izmir 7
Moscow 7
Nanchang 7
Tianjin 7
Milan 6
London 5
Redwood City 5
Venezia 5
Brussels 4
Düsseldorf 4
Jiaxing 4
San Mateo 4
Brno 3
Changchun 3
Hebei 3
Hefei 3
Jinan 3
Los Angeles 3
Olomouc 3
San Francisco 3
Sesto San Giovanni 3
Shenyang 3
Acerra 2
Amman 2
Bangalore 2
Guangzhou 2
Lappeenranta 2
Manchester 2
Málaga 2
Ningbo 2
Norwalk 2
Philadelphia 2
Prescot 2
Toronto 2
Winnipeg 2
Auburn Hills 1
Baku 1
Bangkok 1
Cairo 1
Changsha 1
Chengdu 1
Edinburgh 1
Frascati 1
Guayaquil 1
Kilburn 1
Kunming 1
Lanzhou 1
Madrid 1
Montevarchi 1
Munich 1
Nasugbu 1
Oslo 1
Rockville 1
Santa Clara 1
Singapore 1
Tappahannock 1
Tokyo 1
Washington 1
Zanjan 1
Zhengzhou 1
Zurich 1
Totale 1.767
Nome #
Prodrugs of pyrazolo[3,4-d]pyrimidines: from library synthesis to evaluation as potential anticancer agents in an orthotopic glioblastoma model 259
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction. 184
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 177
Arylation of 2-Furyl 4-Fluorophenyl Ketone: an extension of Heck Chemistry towards Novel Integrase Inhibitors 169
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3s case 161
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant 156
Discovery of 14-3-3 Protein-Protein Interaction Inhibitors that Sensitize Multidrug-Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693 155
Small molecules modulation of 14-3-3 protein–protein interactions 137
null 137
An alternative synthetic approach for the synthesis of biologically relevant 1,4-disubstituted pyrazolo[3,4-d]pyrimidines 126
A Versatile and Practical Synthesis toward the Development of Novel HIV-1 Integrase Inhibitors 126
Exploring the chemical space around the privileged pyrazolo[3,4-d]pyrimidine scaffold: toward novel allosteric inhibitors of T315I-mutated Abl. 120
Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing 115
AuNP Pyrazolo[3,4-d]pyrimidine Nanosystem in Combination with Radiotherapy against Glioblastoma 99
COMPOUNDS AND USES THEREOF 55
Totale 2.176
Categoria #
all - tutte 6.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020456 55 16 29 65 37 36 40 52 41 44 17 24
2020/2021311 9 35 2 38 35 44 14 40 22 33 24 15
2021/2022225 27 33 5 7 7 7 14 4 5 35 32 49
2022/2023314 19 36 37 48 31 55 11 34 24 6 12 1
2023/2024264 6 5 18 14 8 78 90 15 1 12 3 14
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 2.176